Status:
COMPLETED
Study on Glycemic Variations in Diabetic Patients Treated With Chemotherapy: Benefit of Continuous Interstitial Glucose Measurement
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Diabetes
Chemotherapy
Eligibility:
All Genders
18+ years
Brief Summary
Over the last years, there has been a progressive increase in the prevalence of diabetes. Approximately 3.3 million French adults and approximately 425 million adults worldwide have been diagnosed wit...
Eligibility Criteria
Inclusion
- Person who has provided oral consent
- Diabetic cancer patient starting chemotherapy for the first time or after a period of remission of at least 6 months.
Exclusion
- Person not affiliated to French National Health Insurance
- Person subject to legal protection (guardianship, trusteeship)
- Person subject to partial justice safeguard measure
- Pregnant, parturient or breastfeeding woman
- Adult unable to provide consent
- Minor
Key Trial Info
Start Date :
June 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 6 2022
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04315857
Start Date
June 9 2020
End Date
April 6 2022
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000